Neurology-neuroimmunology & Neuroinflammation SCISCIE

Neurology: Neuroimmunology & NeuroInflammation is an official journal of the American Academy of Neurology.

Vision: Our vision is to be the premier peer-reviewed journal for experts in the fields of neuroimmunology and neuroinflammation.

Mission: The mission of Neurology Neuroimmunology & Neuroinflammation is to provide neurologists and translationally minded scientists with peer-reviewed articles, editorials, and reviews to enhance patient care, education, and clinical & translational research.

We publish rigorously peer-reviewed open access reports of original research and in-depth reviews of topics in neuroimmunology & neuroinflammation, affecting the full range of neurologic diseases including (but not limited to): Alzheimer disease, Parkinson disease, ALS, tauopathy, and stroke; multiple sclerosis and NMO; inflammatory peripheral nerve and muscle disease, Guillain-Barré and myasthenia; nervous system infection; paraneoplastic syndromes, noninfectious encephalitides and other antibody-mediated disorders; and psychiatric and neurodevelopmental disorders. Clinical trials, instructive case reports, and small case series will also be featured.

Neurology: Neuroimmunology & NeuroInflammation 是美国神经病学会的官方期刊。

愿景：我们的愿景是成为神经免疫学和神经炎症领域专家的一流同行评审期刊。

使命：Neurology Neuroimmunology & Neuroinflammation 的使命是为神经学家和具有转化思维的科学家提供同行评议的文章、社论和评论，以加强患者护理、教育以及临床和转化研究。

我们发布经过严格同行评审的开放获取原始研究报告和对神经免疫学和神经炎症主题的深入评论，影响所有神经系统疾病，包括（但不限于）：阿尔茨海默病、帕金森病、ALS、 τ蛋白病和中风；多发性硬化症和 NMO；炎症性周围神经和肌肉疾病、格林巴利和肌无力；神经系统感染；副肿瘤综合征、非感染性脑炎和其他抗体介导的疾病；以及精神和神经发育障碍。临床试验、指导性病例报告和小型病例系列也将成为特色。

该刊已被国际权威数据库SCI、SCIE收录，是国际顶级期刊。该刊致力于发表经过严格同行评审的高质量原创文章，反映Neuroscience-Neurology领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2022年影响因子为8.8，平均审稿速度为8 Weeks，近三年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。